W B Bradford1, B O Jose, D Butler
1University of Louisville, Department of Radiation Oncology, Brown Cancer Center, USA.
Pediatric Rhabdomyosarcoma (RMS) treatment over 10 years showed good survival rates, with 87% actuarial survival. Anatomical site, group, and gender were analyzed as prognostic indicators for overall survival in this study.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: